detection of AR-V7 in blood and circulating tumor cells, antibody to detect AR-V7 in primary tumor tissue influence on staining results, differences in epitope recognition, expression and activity of AR-V7, detection of AR-V7 inducible gene products.
noninvasive biomarker testing and imaging, Prostate Specific Antigen (PSA), PRECISION trial, PSA screening, 4K Score, ExoDx Intelliscore, prostate cancer screening, prostate cancer.
prostate cancer, PARP Inhibitor Therapy, Poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitors, PARP inhibitors, androgen receptor pathway inhibitor (ARPI), homologous recombination repair (HRR) genes, Olaparib plus…
Neuroendocrine carcinoma of the urinary tract (NEC-URO), urothelial carcinoma (UC), optimal management for NEC-URO, neoadjuvant chemotherapy, gemcitabine/cisplatin, etoposide plus cisplatin.
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC AKT inhibitors – Targeting PI3K/AKT/MTOR Signaling Axis – Cora Sternberg Part…
Pedro Barata and Nizar Tannir delve into the eight-year results of the CheckMate-214 trial, showcasing the sustained efficacy of ipilimumab and nivolumab (ipi/nivo) in advanced…
Sam Chang engages with Roger Li to delve into the TAR-210 study, focusing on bladder-based intravesical therapy targeting FGFR3 in non-muscle invasive bladder cancer (NMIBC)…
Zach Klaassen and Kelvin Moses discuss the continuum of care for metastatic hormone-sensitive prostate cancer, focusing on triplet therapy. Dr. Moses highlights the ideal patient…
Jeffrey Tosoian presents a new tool in prostate cancer diagnosis with the development and validation of an 18-gene urine test designed to identify clinically significant…
Alicia Morgans hosts Shankar Siva who sheds light on the innovative use of Stereotactic Ablative Body Radiotherapy (SBRT/SABR) for treating oligometastatic kidney cancer. Dr. Siva…
Prostate cancer, PROpel trial, homologous recombination repair mutation (HRRm), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Olaparib, Abiraterone, Olaparib plus Abiraterone Versus Placebo plus Abiraterone for Metastatic…
